ArticleGut and liver2010
Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.
Article in Gut and liver, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01554007 (Clinical Course of Crohn's Disease), which is not on this map. Cited by 50 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Course of Crohn's Disease: a Prospective Multicenter Long-term Follow-up Study in Korea
Who cites it
50 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The application of Tong-fu therapeutic method on ulcerative colitis: A systematic review and meta-analysis for efficacy and safety of rhubarb-based therapy.Frontiers in pharmacology · 2022Pooled it
- Ameliorative Effects of Newly Developed Citrus Hybrid "Mubong" Peel Extract on Experimental Colitis and Gut Microbiota Dysbiosis.Food science & nutrition · 2026Article
- Article
- Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study.Acta dermato-venereologica · 2024Article
- Article
- Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease.Intestinal research · 2022Article
- Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis.Frontiers in pharmacology · 2022Review
- Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study.Intestinal research · 2021Article
- Effect of Thiopurine on Potential Surgical Intervention in Crohn’s Disease in Korea: Results from the CONNECT StudyJournal of clinical medicine · 2020Article
- Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study.JMIR medical informatics · 2020Article
- Trends and risk factors of elderly-onset Crohn's disease: A nationwide cohort study.World journal of gastroenterology · 2020Article
- Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use.World journal of gastroenterology · 2019Article
- What Are the Major Changes in Korean Inflammatory Bowel Disease Surgery?Annals of coloproctology · 2018Article
- Renal involvement in children and adolescents with inflammatory bowel disease.Korean journal of pediatrics · 2018Article
- Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.Gut and liver · 2018Article
- Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.Inflammatory intestinal diseases · 2017Review
- Ophthalmologic manifestations in patients with inflammatory bowel disease.Intestinal research · 2017Article
- Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases.Intestinal research · 2017Article
- Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.Yonsei medical journal · 2017Article
- Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.Intestinal research · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD) describes chronic inflammatory disease of the intestines and has a variable course; Crohn's disease and ulcerative colitis comprise the two main forms of the condition. Although IBD occurs worldwide, its epidemiologic and clinical characteristics vary depending upon the geographic location and the ethnicity of the population. Identifying the characteristic features of IBD in populations living in different geographical locations and with different ethnicities may provide significant clues about its etiology and pathophysiology, which in turn may be helpful in the development of more appropriate treatment strategies for IBD for these different populations. Therefore, it is important for each country and region to evaluate critically the epidemiology, genomics, and clinical characteristics of IBD among its own population. We have performed a critical review of the recent data in Korea, and describe herein the current epidemiologic and genotypic status, as well as the clinical manifestations and therapeutic responses of IBD that are unique to Korean patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.